N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity:: Part I

被引:327
作者
Thorneloe, Kevin S. [1 ]
Sulpizio, Anthony C. [1 ]
Lin, Zuojun [1 ]
Figueroa, David J. [1 ]
Clouse, Angela K. [1 ]
McCafferty, Gerald P. [1 ]
Chendrimada, Tim P. [1 ]
Lashinger, Erin S. R. [1 ]
Gordon, Earl [1 ]
Evans, Louise [1 ]
Misajet, Blake A. [1 ]
DeMarini, Douglas J. [2 ]
Nation, Josephine H. [3 ]
Casillas, Linda N. [2 ]
Marquis, Robert W. [2 ]
Votta, Bartholomew J. [2 ]
Sheardown, Steven A. [3 ]
Xu, Xiaoping [1 ]
Brooks, David P. [1 ]
Laping, Nicholas J. [1 ]
Westfall, Timothy D. [1 ]
机构
[1] GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
[2] GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA USA
[3] GlaxoSmithKline, Transgen Genotyping & Viral Vectors, Harlow, Essex, England
关键词
D O I
10.1124/jpet.108.139295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The transient receptor potential (TRP) vanilloid 4 (TRPV4) member of the TRP superfamily has recently been implicated in numerous physiological processes. In this study, we describe a small molecule TRPV4 channel activator, (N-((1S)-1-{[4-((2S)-2{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl] carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), which we have used as a valuable tool in investigating the role of TRPV4 in the urinary bladder. GSK1016790A elicited Ca2+ influx in mouse and human TRPV4-expressing human embryonic kidney (HEK) cells (EC50 values of 18 and 2.1 nM, respectively), and it evoked a dose-dependent activation of TRPV4 whole-cell currents at concentrations above 1 nM. In contrast, the TRPV4 activator 4 alpha-phorbol 12,13-didecanoate (4 alpha-PDD) was 300-fold less potent than GSK1016790A in activating TRPV4 currents. TRPV4 mRNA was detected in urinary bladder smooth muscle (UBSM) and urothelium of TRPV4(+/+) mouse bladders. Western blotting and immunohistochemistry demonstrated protein expression in both the UBSM and urothelium that was absent in TRPV4(-/-) bladders. TRPV4 activation with GSK1016790A contracted TRPV4(+/+) mouse bladders in vitro, both in the presence and absence of the urothelium, an effect that was undetected in TRPV4(-/-) bladders. Consistent with the effects on TRPV4 HEK whole-cell currents, 4 alpha-PDD demonstrated a weak ability to contract bladder strips compared with GSK1016790A. In vivo, urodynamics in TRPV4(+/+) and TRPV4(-/-) mice revealed an enhanced bladder capacity in the TRPV4(-/-) mice. Infusion of GSK1016790A into the bladders of TRPV4(+/+) mice induced bladder overactivity with no effect in TRPV4(-/-) mice. Overall TRPV4 plays an important role in urinary bladder function that includes an ability to contract the bladder as a result of the expression of TRPV4 in the UBSM.
引用
收藏
页码:432 / 442
页数:11
相关论文
共 40 条
[1]   A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators [J].
Alessandri-Haber, N ;
Dina, OA ;
Joseph, EK ;
Reichling, D ;
Levine, JD .
JOURNAL OF NEUROSCIENCE, 2006, 26 (14) :3864-3874
[2]   Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier [J].
Alvarez, Diego F. ;
King, Judy A. ;
Weber, David ;
Addison, Emile ;
Liedtke, Wolfgang ;
Townsley, Mary I. .
CIRCULATION RESEARCH, 2006, 99 (09) :988-995
[3]   Swelling-activated Ca2+ entry via TRPV4 channel is defective in cystic fibrosis airway epithelia [J].
Arniges, M ;
Vázquez, E ;
Fernández-Fernández, JM ;
Valverde, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) :54062-54068
[4]   TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications [J].
Avelino, Antonio ;
Cruz, Francisco .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (04) :287-299
[5]   Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1 [J].
Birder, LA ;
Nakamura, Y ;
Kiss, S ;
Nealen, ML ;
Barrick, S ;
Kanai, AJ ;
Wang, E ;
Ruiz, G ;
de Groat, WC ;
Apodaca, G ;
Watkins, S ;
Caterina, MJ .
NATURE NEUROSCIENCE, 2002, 5 (09) :856-860
[6]   Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells [J].
Birder, LA ;
Kanai, AJ ;
de Groat, WC ;
Kiss, S ;
Nealen, ML ;
Burke, NE ;
Dineley, KE ;
Watkins, S ;
Reynolds, IJ ;
Caterina, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) :13396-13401
[7]   Activation of urothelial transient receptor potential vanilloid 4 by 4α-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat [J].
Birder, Lori ;
Kullmann, F. Aura ;
Lee, Hyosang ;
Barrick, Stacey ;
de Groat, William ;
Kanai, Anthony ;
Caterina, Michael .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01) :227-235
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   Morphology and localization of interstitial cells in the guinea pig bladder: Structural relationships with smooth muscle and neurons [J].
Davidson, RA ;
McCloskey, KD .
JOURNAL OF UROLOGY, 2005, 173 (04) :1385-1390
[10]   Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2 [J].
Delany, NS ;
Hurle, M ;
Facer, P ;
Alnadaf, T ;
Plumpton, C ;
Kinghorn, I ;
See, CG ;
Costigan, M ;
Anand, P ;
Woolf, CJ ;
Crowther, D ;
Sanseau, P ;
Tate, SN .
PHYSIOLOGICAL GENOMICS, 2001, 4 (03) :165-174